Visirna Therapeutics Hk Limited
Clinical trials sponsored by Visirna Therapeutics Hk Limited, explained in plain language.
-
Breakthrough injection slashes Sky-High fats in rare genetic disease
Disease control CompletedThis study tested an injectable drug called Plozasiran in 37 Chinese adults with Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder causing extremely high blood fats that can lead to severe pancreatitis. The main goal was to see if the drug safely lowers triglycerid…
Phase: PHASE3 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
New cholesterol drug VSA003 tested for safety in healthy volunteers
Knowledge-focused CompletedThis early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults with mildly high cholesterol or triglycerides. The main goal was to check safety and how the drug moves through the body, not to treat the condition. Participants were monitored for side effects an…
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC